|
EIF2AK3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.960400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.145600E-01 |
| Normal-vs-Stage2 |
7.559000E-01 |
| Normal-vs-Stage3 |
7.796800E-01 |
| Normal-vs-Stage4 |
2.731200E-01 |
| Stage1-vs-Stage2 |
8.659800E-01 |
| Stage1-vs-Stage3 |
5.820200E-01 |
| Stage1-vs-Stage4 |
1.300370E-01 |
| Stage2-vs-Stage3 |
6.247200E-01 |
| Stage2-vs-Stage4 |
2.140800E-01 |
| Stage3-vs-Stage4 |
4.762600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.973800E-01 |
| Normal-vs-AfricanAmerican |
6.873000E-01 |
| Normal-vs-Asian |
8.518600E-01 |
| Caucasian-vs-AfricanAmerican |
7.401600E-01 |
| Caucasian-vs-Asian |
8.505200E-01 |
| AfricanAmerican-vs-Asian |
7.319000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.391200E-01 |
| Normal-vs-Female |
2.107800E-01 |
| Male-vs-Female |
4.961700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.210220E-01 |
| Normal-vs-Age(41-60Yrs) |
8.425200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.353000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.457400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.711210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.984200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.514000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.988800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.753600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.617000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.626000E-01 |
| Normal-vs-Grade 2 |
7.427600E-01 |
| Normal-vs-Grade 3 |
6.853600E-01 |
| Normal-vs-Grade 4 |
3.842400E-01 |
| Grade 1-vs-Grade 2 |
8.290200E-01 |
| Grade 1-vs-Grade 3 |
5.940800E-01 |
| Grade 1-vs-Grade 4 |
3.379400E-01 |
| Grade 2-vs-Grade 3 |
3.882800E-01 |
| Grade 2-vs-Grade 4 |
1.803410E-01 |
| Grade 3-vs-Grade 4 |
5.715200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.385600E-01 |
| Normal-vs-ccB subtype |
7.939600E-01 |
| ccA subtype-vs-ccB subtype |
7.072400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.170200E-01 |
| Normal-vs-N1 |
6.003800E-01 |
| N0-vs-N1 |
7.381400E-01 |
|
|
